Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Hengdian Group Acquires Jiali Industry in Largest M&A in Company’s History
-
Prepayments (CK93) - Totalkredit A/S
-
Hengdian Group Acquires Jiali Industry in Largest M&A in Company’s History
-
Crypto News Today: AlphaPepe Presale Stage 20 Nears Sell Out as Dogecoin Price Prediction Eyes $1
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
50/2026・Trifork Group: Weekly report on share buyback
-
Name Change and Consolidation Approved
-
Top 5 SMM Panels in India for 2026: Detailed Comparison
-
Festi hf.: Transactions in relation to a share repurchase programme - week 34
-
FOREX.com launches the first overnight Japan Stock CFDs and Japan Stock CFD Knock-Out Options service
-
First German GHG trade initiated on Argus Open Markets platform
-
OSL's StableHub Records Over US$200 Million in USDC Deposits in Four Months
-
OSL's StableHub Records Over US$200 Million in USDC Deposits in Four Months
-
Green Choice Proteins Expands U.S. Rollout With Upcoming Amazon Launch
-
Jungbunzlauer improves EcoVadis score and remains among the top 2% of companies worldwide
-
KPMG PRI becomes first verification body accredited by ANAB for Section 45Z clean fuel certifications
-
UK Credit Card Payment Rates Drop and Card Balances Rise as Summer Spending Puts Pressure on Consumers
-
Ripjar Strengthens Leadership Team as Demand Rises for Smarter Customer Screening
-
Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization
-
International Petroleum Corporation Announces Results of Normal Course Issuer Bid
-
Kailas FUGA Opens Chamonix Store with FUGA EX PRO G Launch
-
As Global Electricity Demand Rises, Power Queen Unveils “Power What Matters.” to Power What Truly Matters
-
Keeping Europe's rail networks moving through precision machining
-
Danske Bank share buy-back programme: transactions in week 34
-
International Petroleum Corporation Announces Results of Normal Course Issuer Bid
-
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
-
Axi Refreshes Its Brand Identity with The Launch of a New Website
-
NRG Therapeutics Presents Data on Lead Clinical Asset NRG5051 Confirming Novel Disease-Modifying Approach to ALS
-
Transactions in connection with share buyback programme
-
Latest Crypto News: Best Upcoming Meme Coin Presale to Invest in 2026 with 100X Potential vs. SHIB and PNUT
-
Jetex Announces Opening in Sofia
-
Resecurity and the National Cybercrime Unit of the National Police of Ecuador (CiberPOL) Signed a Memorandum of Understanding (MoU) to Strengthen the Prevention and Investigation of Cybercrimes
-
Cwallet Launches Integrated Social Ecosystem to Eliminate Web3's Cross-Platform Security Gap
-
Cwallet Launches Integrated Social Ecosystem to Eliminate Web3's Cross-Platform Security Gap
-
Scania to showcase its broad marine offering at SMM 2026
-
Correction: Notice of the public offering of Hepsor AS bonds
-
MLM Software vs. Affiliate Program Platforms: 2026 Comparison for Network Marketing
-
Paysafe Launches Video Gaming Arena to Connect Publishers with Millions of Gamers
-
Share buybacks in Ericsson during the period August 17 - August 21, 2026
-
ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
-
European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union
-
Corinex Launches Grid Intelligence Node to Reveal the True State of the Low-Voltage Grid
-
Daiichi Sankyo Appoints Ken Keller as Chief Commercialization Officer to Lead New Commercialization Unit to Accelerate Growth of Innovative Portfolio
-
Iberia Cards Moves Beyond Point-in-Time Compliance with Synack
-
From Data to Doorsteps: How Kim Lundgren Associates Is Helping Local Governments Make Climate Action Personal
-
Emerson's Advanced Measurement Instrumentation Selected by Equinor to Optimize Operations, Accelerate Development
-
Share buyback programme – week 34
-
Aktietilbagekøb i SJF Bank A/S – transaktioner i uge 34
-
Prepayments, Realkredit Danmark A/S
-
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
